Editorial Comment

Abstract

The present series illustrates important points regarding contemporary management of prostate cancer and renal transplant recipients. First, patients who have been successfully treated for end-stage renal disease by renal transplantation are healthy, have an excellent life expectancy, and are subject to acquiring further medical conditions that will require definitive management. This includes prostate cancer, which will be frequently found. These patients should be screened and treated for prostate cancer. Second, radical prostatectomy is a feasible and reasonable option for solid organ transplant recipients. The current finding of a high incidence of severe prostatitis, which resulted in rectal injury, is a novel and important observation. We have not observed this phenomenon. It certainly deserves more scrutiny to identify preoperative factors that may predict surgical difficulty. There does not appear to be any smoking gun in the present series, which correlates to the complications observed. In management of rectal injury, we strongly advise reducing the patient's immunosuppressive therapy as much as possible to encourage healing. Rapimmune has greater potential than Cellcept for impairing closure of the rectal injury. Consideration should, therefore, be given to changing the patient's medication regimen to reduce the possibility of serious complications. Laparoscopic Radical Prostatectomy in Renal Transplant RecipientsUrologyVol. 74Issue 3PreviewTo report our experience with 9 consecutive laparoscopic radical prostatectomy (LRP) on renal transplant recipients (RTR) and to compare it with other LRPs performed during the same period by the same surgeons. Retropubic radical prostatectomy has widely been described in RTR, whereas LRP has rarely been studied. Full-Text PDF